Chokka, Pratap

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 1,090

Adult ADHD and comorbid disorders: clinical implications of a dimensional approach

Katzman, M. A., Bilkey, T. S., Chokka, P. R., Fallu, A., & Klassen, L. J. (2017) · BMC Psychiatry

Attention Deficit Hyperactivity DisorderSchizophrenia research and treatment

Cited by 732

Adult ADHD and its comorbidities, with a focus on bipolar disorder

Klassen, L. J., Katzman, M. A., & Chokka, P. (2010) · Journal of Affective Disorders

Attention Deficit Hyperactivity DisorderBipolar Disorder and Treatment

Cited by 205

Esketamine for treatment resistant depression

Swainson, J., Thomas, R. K., Archer, S., Chrenek, C., MacKay, M.-A., Baker, G., Dursun, S., Klassen, L. J., Chokka, P., & Demas, M. L. (2019) · Expert Review of Neurotherapeutics

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 151

Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment

Walker, J. R., Van Ameringen, M. A., Swinson, R., Bowen, R. C., Chokka, P. R., Goldner, E., Johnston, D. C., Lavallie, Y.-J., Nandy, S., Pecknold, J. C., et al. (2000) · Journal of Clinical Psychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSchizophrenia research and treatment

Cited by 84

Functional Recovery in Major Depressive Disorder: Focus on Early Optimized Treatment

Habert, J., Katzman, M. A., Oluboka, O. J., McIntyre, R. S., McIntosh, D., MacQueen, G. M., Khullar, A., Milev, R. V., Kjernisted, K. D., Chokka, P. R., et al. (2016) · The Primary Care Companion For CNS Disorders

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 84

Comorbid Attention Deficit/Hyperactivity Disorder and Substance Use Disorder: Treatment Considerations

J. Klassen, L., S. Bilkey, T., A. Katzman, M., & Chokka, P. (2012) · Current Drug Abuse Reviewse

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 54

Assessment in work productivity and the relationship with cognitive symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD)

Chokka, P., Bougie, J., Rampakakis, E., & Proulx, J. (2019) · CNS Spectrums

Treatment of Major DepressionWorkplace Health and Well-being

Cited by 48

Re: Is Adult Attention-Deficit Hyperactivity Disorder Being Overdiagnosed?

Katzman, M. A., Bilkey, T., Chokka, P. R., Fallu, A., & Klassen, L. J. (2016) · The Canadian Journal of Psychiatry

Cited by 17